Premium
Sclerotherapy for the mucoceles of the anterior lingual salivary glands with pingyangmycin
Author(s) -
Cai Y,
Wang R,
Yang SF,
Zhao YF,
Zhao JH
Publication year - 2014
Publication title -
oral diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.953
H-Index - 87
eISSN - 1601-0825
pISSN - 1354-523X
DOI - 10.1111/odi.12155
Subject(s) - pingyangmycin , medicine , sclerotherapy , mucocele , surgery , local anesthesia , hemangioma
Recurrence is very common if the mucoceles of the anterior lingual salivary glands (ALSGs) are treated by surgery due to its anatomic characteristics. Therefore, more effective and less invasive treatment methods are urgently required to be applied instead of surgery. In this study, 40 patients with the mucocele of the ALSGs received the intralesional injections of pingyangmycin, and the median number of injections per patient was 2.075 (range, 1–3). All cases completely recovered with no recurrence after follow‐up of more than 16 months. The complications included the local swelling, pain, and ulceration following injection, and all these symptoms resolved 7–10 days after the injection. Taken together, sclerotherapy with pingyangmycin is an effective and safe treatment method for the mucocele of the ALSGs and may be the primary treatment modality.